Etiket: BioNTech
NASDAQ title BioNTech share in red premarket: BioNTech expects sales to fall significantly in the 2024 financial year
The Mainz-based vaccine manufacturer BioNTech expects sales to fall significantly in the 2024 financial year due to shrinking sales of the Covid-19 vaccine. The company announced on Tuesday at the…
NASDAQ title CureVac shares lower again after record low: Evercore analyst sees good basis for appeal in BioNTech legal dispute
After the previous day’s record low, CureVac’s shares attempted to stabilize on Wednesday. At a time of 4.2997 euros, the vaccine manufacturer’s papers in NASDAQ trading broke away from the…
NASDAQ value CureVac share falls by over 30 percent: CureVac suffers a setback in the vaccine patent dispute with BioNTech
The Federal Patent Court has declared a basic corona vaccine patent from the Tübingen pharmaceutical company CureVac invalid. The shares of the Tübingen company CureVac then lost a good third…
BioNTech presents cancer vaccination
From BZ Is it the beginning of the end for the horror disease? In Germany alone, around 240,000 people die of cancer every year. The local biotechnology company Biontech from…
STOCKS IN FOCUS 2: Pfizer defy forecast cut – Moderna and Biontech are sinking
(new: prices after the stock market opened, Pfizer turned positive, further analyst opinions) NEW YORK (dpa-AFX) – Pfizer investors quickly put up with a forecast cut on Monday. The US…
Pfizer shares and BioNTech shares under pressure after trading: COVID medicines not in demand – Pfizer lowers annual forecast
The collapse in demand for COVID medication is significantly slowing down the US pharmaceutical company Pfizer’s business. On Friday, the industry giant cut its sales forecast for the current year…
NASDAQ stock BioNTech stock in green: EU Commission approves updated version of corona vaccine – Pfizer stock higher
On Friday, the European Commission approved the updated corona vaccine from the Mainz-based manufacturer BioNTech and its US partner Pfizer. It is to be used in the vaccination campaigns of…
Legal notice to the vaccine manufacturer BioNTech because of the change in the status of the corona virus | Buitenland
Volgens de righter zal het voor de man real moeilijk zijn om zijn slag thuis te halen. So it is bijvoorbeeld geen front tot vergevergoeding mogelijk as de risk-batenanalyse van…
BioNTech share: More than 200 claims for damages in Germany against vaccine manufacturers
In the run-up to the damages process against the vaccine manufacturer BioNTech starting Monday in a German court, the German Ministry of Health has given the number of pending court…
Woman demands 150,000 euros from Biontech!
By Marion Helmes Vaccine manufacturer Biontech in court! The accusation: damage to health from the corona vaccine! The plaintiff is a doctor from Hamburg. She suffers from upper body pain,…